Background: Ubiquitous digital technologies such as smartphone sensors promise to
fundamentally change biomedical research and treatment monitoring in neurological diseases …

Digital health technologies enable remote and therefore frequent measurement of motor
signs, potentially providing reliable and valid estimates of motor sign severity and progression …

Background Aggregated α-synuclein plays an important role in the pathogenesis of Parkinson’s
disease. The monoclonal antibody prasinezumab, directed at aggregated α-synuclein, is …

Background: Current clinical assessments of people with multiple sclerosis are episodic and
may miss critical features of functional fluctuations between visits. Objective: The goal of the …

Background: Sensor-based monitoring tools fill a critical gap in multiple sclerosis (MS)
research and clinical care. Objective: The aim of this study is to assess performance …

Monoclonal antibodies (mAbs) and proteins containing antibody domains are the most
prevalent class of biotherapeutics in diverse indication areas. Today, established techniques …

Smartphone-based assessments have been considered a potential solution to passively
monitor gait and mobility in early-stage Parkinson's disease (PD) patients. In the Multiple …

Background Remote monitoring of Huntington disease (HD) signs and symptoms using digital
technologies may enhance early clinical diagnosis and tracking of disease progression, …

Digital health technology tools (DHTT) are technologies such as apps, smartphones, and
wearables that remotely acquire health-related information from individuals. They have the …

Objective: Parkinson's disease (PD) is a neurodegenerative disorder that affects multiple
neurological systems. Traditional PD assessment is conducted by a physician during infrequent …